Cancer-associated antigen
The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.
1. A method of detecting cancer cells or monitoring cancer in a subject having or suspected of having cancer, comprising detecting a cancer-associated variant of Mammalian Scratch, wherein the cancer-associated variant of Mammalian Scratch comprises a transmembrane domain comprising the amino acid sequence as shown in SEQ ID NO:2, on a cell in a sample from the subject, wherein cancer is indicated, if the cancer-associated variant of Mammalian Scratch is detected on the cell.
2. A method of detecting cancer cells or monitoring cancer in a subject having or suspected of having cancer comprising:
(a) contacting a sample from the subject with an antibody that binds to a cancer-associated variant of Mammalian Scratch comprising a transmembrane domain comprising the amino acid sequence as shown in SEQ ID NO:2;
(b) detecting the level of the cancer-associated variant of Mammalian Scratch in the sample; and
(c) comparing the level of the cancer-associated variant of Mammalian Scratch in the sample to a control sample, wherein increased levels of the cancer-associated variant of Mammalian Scratch as compared to the control indicates that the subject has cancer.
3. A method of detecting cancer cells or monitoring cancer in a subject having or suspected of having cancer, comprising detecting a cancer-associated variant of Mammalian Scratch comprising the amino acid sequence as shown in SEQ ID NO:1, wherein the cancer-associated variant of Mammalian Scratch comprises a transmembrane domain, on a cell in a sample from the subject, wherein cancer is indicated, if the cancer-associated variant of Mammalian Scratch is detected on the cell.
4. A method of detecting cancer cells or monitoring cancer in a subject having or suspected of having cancer comprising:
(a) contacting a sample from the subject with an antibody that binds to a cancer-associated variant of Mammalian Scratch comprising the amino acid sequence as shown in SEQ ID NO:1;
(b) detecting the level of the cancer-associated variant of Mammalian Scratch in the sample; and
(c) comparing the level of the cancer-associated variant of Mammalian Scratch in the sample to a control sample, wherein increased levels of the cancer-associated variant of Mammalian Scratch as compared to the control indicates that the subject has cancer.